Primary diffuse large B cell lymphoma of the uterine cervix successfully treated by combined chemotherapy alone: A case report

[EN]Rationale: Primary lymphomas of the uterine cervix are a rare disease. They are often misdiagnosed because of their rarity and because they can be easily confused with a squamous cell carcinoma of the cervix, as they are usually presented as exophytic mass with vaginal bleeding as their most com...

Descripción completa

Detalles Bibliográficos
Autores: Cubo Nava, Ana María, Soto, Zandra Mileny, Cruz, Miguel Ángel, Doyague Sanchez, María José, Sancho, Verónica, Fraino, Aurymar, Blanco Muñez, Óscar Javier, Puig Morón, Noemí, Alcoceba Sánchez, Miguel, González, Marcos, Sayagués Manzano, José María
Tipo de recurso: artículo
Fecha de publicación:2017
País:España
Institución:Universidad de Salamanca (USAL)
Repositorio:GREDOS. Repositorio Institucional de la Universidad de Salamanca
OAI Identifier:oai:gredos.usal.es:10366/154917
Acceso en línea:http://hdl.handle.net/10366/154917
Access Level:acceso abierto
Palabra clave:Diffuse-large B-cell lymphoma
Extranodal lymphoma
Non-Hodgkin lymphoma
Primary cervix B-cell lymphoma
Cervix Uteri
cuello del útero
Descripción
Sumario:[EN]Rationale: Primary lymphomas of the uterine cervix are a rare disease. They are often misdiagnosed because of their rarity and because they can be easily confused with a squamous cell carcinoma of the cervix, as they are usually presented as exophytic mass with vaginal bleeding as their most common symptoms. Nevertheless, considering that both the prognosis and the treatment are completely different between them, differential diagnosis should be taken into account. Patient concerns: A case of a 51-year-old woman with a primary diffuse large B-cell lymphoma of the cervix is presented. Diagnoses: Diagnosis of this tumor was a challenge for pathologists and clinicians, as four biopsies were needed to achieve a final diagnosis. Interventions: Patient was successfully treated with combined Rituximab and chemotherapy (R-CHOP) alone. Outcomes: Complete remission, confirmed through biopsy, was reached after six courses of chemotherapy. At 2-years follow up, patient is alive and free of disease. Lessons: Considering that the prognosis and treatment of primary malignant lymphoma of the cervix are completely different than that of the squamous cell carcinoma, awareness of this disease should be considered in the differential diagnosis. Abbreviations: CHOP = cyclophosphamide, doxorubicin, vincristine and prednisolone, CT scan = computerized tomography scan, ECOG = Eastern cooperative oncology group, FIGO = International Federation of Gynecology and Obstetrics, IPI = International prognostic index, LLL = lymphoma-like lesions, MALT-lymphoma = mucosa-associated lymphoid tissue lymphoma, MRI = magnetic resonance imaging, NHL = non-Hodgkin lymphomas, R-CHOP = rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone.